Cargando…

Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management

Objective. The aim of this review is to explore the role of IGF-1 and IGF-1R inhibitors in pain-related conditions and assess the effectiveness of IGF-1-related drugs in pain management. Specifically, this paper investigates the potential involvement of IGF-1 in nociception, nerve regeneration, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Seokhyun, Cheng, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224460/
https://www.ncbi.nlm.nih.gov/pubmed/37242543
http://dx.doi.org/10.3390/ph16050760
_version_ 1785050189731463168
author Jin, Seokhyun
Cheng, Jianguo
author_facet Jin, Seokhyun
Cheng, Jianguo
author_sort Jin, Seokhyun
collection PubMed
description Objective. The aim of this review is to explore the role of IGF-1 and IGF-1R inhibitors in pain-related conditions and assess the effectiveness of IGF-1-related drugs in pain management. Specifically, this paper investigates the potential involvement of IGF-1 in nociception, nerve regeneration, and the development of neuropathic pain. Methods. We conducted a search of the PUBMED/MEDLINE database, Scopus, and the Cochrane Library for all reports published in English on IGF-1 in pain management from origination through November 2022. The resulting 545 articles were screened, and 18 articles were found to be relevant after reading abstracts. After further examination of the full text of these articles, ten were included in the analysis and discussion. The levels of clinical evidence and implications for recommendations of all the included human studies were graded. Results. The search yielded 545 articles, of which 316 articles were deemed irrelevant by reading the titles. There were 18 articles deemed relevant after reading abstracts, of which 8 of the reports were excluded due to lack of IGF-1-related drug treatment after reviewing the full text of the articles. All ten articles were retrieved for analysis and discussion. We found that IGF-1 may have several positive effects on pain management, including promoting the resolution of hyperalgesia, preventing chemotherapy-induced neuropathy, reversing neuronal hyperactivity, and elevating the nociceptive threshold. On the other hand, IGF-1R inhibitors may alleviate pain in mice with injury of the sciatic nerve, bone cancer pain, and endometriosis-induced hyperalgesia. While one study showed marked improvement in thyroid-associated ophthalmopathy in humans treated with IGF-1R inhibitor, two other studies did not find any benefits from IGF-1 treatment. Conclusions. This review highlights the potential of IGF-1 and IGF-1R inhibitors in pain management, but further research is needed to fully understand their efficacy and potential side effects.
format Online
Article
Text
id pubmed-10224460
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102244602023-05-28 Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management Jin, Seokhyun Cheng, Jianguo Pharmaceuticals (Basel) Review Objective. The aim of this review is to explore the role of IGF-1 and IGF-1R inhibitors in pain-related conditions and assess the effectiveness of IGF-1-related drugs in pain management. Specifically, this paper investigates the potential involvement of IGF-1 in nociception, nerve regeneration, and the development of neuropathic pain. Methods. We conducted a search of the PUBMED/MEDLINE database, Scopus, and the Cochrane Library for all reports published in English on IGF-1 in pain management from origination through November 2022. The resulting 545 articles were screened, and 18 articles were found to be relevant after reading abstracts. After further examination of the full text of these articles, ten were included in the analysis and discussion. The levels of clinical evidence and implications for recommendations of all the included human studies were graded. Results. The search yielded 545 articles, of which 316 articles were deemed irrelevant by reading the titles. There were 18 articles deemed relevant after reading abstracts, of which 8 of the reports were excluded due to lack of IGF-1-related drug treatment after reviewing the full text of the articles. All ten articles were retrieved for analysis and discussion. We found that IGF-1 may have several positive effects on pain management, including promoting the resolution of hyperalgesia, preventing chemotherapy-induced neuropathy, reversing neuronal hyperactivity, and elevating the nociceptive threshold. On the other hand, IGF-1R inhibitors may alleviate pain in mice with injury of the sciatic nerve, bone cancer pain, and endometriosis-induced hyperalgesia. While one study showed marked improvement in thyroid-associated ophthalmopathy in humans treated with IGF-1R inhibitor, two other studies did not find any benefits from IGF-1 treatment. Conclusions. This review highlights the potential of IGF-1 and IGF-1R inhibitors in pain management, but further research is needed to fully understand their efficacy and potential side effects. MDPI 2023-05-18 /pmc/articles/PMC10224460/ /pubmed/37242543 http://dx.doi.org/10.3390/ph16050760 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Jin, Seokhyun
Cheng, Jianguo
Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management
title Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management
title_full Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management
title_fullStr Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management
title_full_unstemmed Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management
title_short Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management
title_sort insulin-like growth factor-1 (igf-1) related drugs in pain management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224460/
https://www.ncbi.nlm.nih.gov/pubmed/37242543
http://dx.doi.org/10.3390/ph16050760
work_keys_str_mv AT jinseokhyun insulinlikegrowthfactor1igf1relateddrugsinpainmanagement
AT chengjianguo insulinlikegrowthfactor1igf1relateddrugsinpainmanagement